Literature DB >> 9440401

Nationwide oral poliovirus vaccination campaign and the incidence of Guillain-Barré Syndrome.

E Kinnunen1, O Junttila, J Haukka, T Hovi.   

Abstract

A retrospective analysis of the incidence of Guillain-Barré syndrome (GBS) in Finland in 1981-1986 was carried out by careful examination of medical records identified from nationwide Hospital Discharge Register data based on a mean total population of 5 million people. Records from 247 patients fulfilled the accepted criteria of GBS corresponding to a mean annual incidence of 0.82 per 100,000 population. Monthly rates showed an increased incidence of GBS in March 1985, following by a few weeks the onset of the nationwide oral poliovirus vaccine campaign and partly overlapping it. Analysis of the time series in depth suggested, however, that a change point in the occurrence of GBS had already taken place before the oral poliovirus vaccine campaign. Widespread circulation of wild-type 3 poliovirus in the population immediately preceded the oral poliovirus vaccine campaign and the peak occurrence of GBS. These results demonstrate a temporal association between poliovirus infection, caused by either wild virus or live attenuated vaccine, and an episode of increased occurrence of GBS, but they cannot prove the suspected cause-effect relation between GBS and oral poliovirus vaccine administration.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9440401     DOI: 10.1093/oxfordjournals.aje.a009369

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  8 in total

Review 1.  Guillain-Barré syndrome.

Authors:  U Seneviratne
Journal:  Postgrad Med J       Date:  2000-12       Impact factor: 2.401

2.  Guillain-Barre syndrome following oral polio vaccination.

Authors:  Salman Naeem; Asma Shabbir; Abdus Salam Khan; Samia Ahmad; Khawaja Junaid Mustafa; Ammad Fahim
Journal:  J Neurovirol       Date:  2015-12-14       Impact factor: 2.643

Review 3.  Guillain-Barré syndrome--a classical autoimmune disease triggered by infection or vaccination.

Authors:  Eitan Israeli; Nancy Agmon-Levin; Miri Blank; Joab Chapman; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2012-04       Impact factor: 8.667

Review 4.  Safety of routine childhood vaccinations. An epidemiological review.

Authors:  R T Chen; G Mootrey; F DeStefano
Journal:  Paediatr Drugs       Date:  2000 Jul-Aug       Impact factor: 3.930

Review 5.  Vaccines and Guillain-Barré syndrome.

Authors:  Penina Haber; James Sejvar; Yann Mikaeloff; Frank DeStefano
Journal:  Drug Saf       Date:  2009       Impact factor: 5.228

6.  Guillain-Barré syndrome and preceding infection with campylobacter, influenza and Epstein-Barr virus in the general practice research database.

Authors:  Clarence C Tam; Sarah J O'Brien; Irene Petersen; Amir Islam; Andrew Hayward; Laura C Rodrigues
Journal:  PLoS One       Date:  2007-04-04       Impact factor: 3.240

7.  Epidemiology of Guillain-Barré syndrome in Finland 2004-2014.

Authors:  Jussi O T Sipilä; Merja Soilu-Hänninen; Jori O Ruuskanen; Päivi Rautava; Ville Kytö
Journal:  J Peripher Nerv Syst       Date:  2017-11-15       Impact factor: 3.494

8.  Incidence, Disability, and Mortality in Patients With Guillain-Barré Syndrome in Korea: A Nationwide Population-Based Study.

Authors:  Sang-Wook Yi; Jung Hwan Lee; Ji-Man Hong; Young-Chul Choi; Hyung Jun Park
Journal:  J Clin Neurol       Date:  2022-01       Impact factor: 3.077

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.